Pub Date : 2024-06-01DOI: 10.36347/sasjm.2024.v10i06.001
Aboubacar Sangaré, Mohamed Diabaté, Korotoum W. Diallo, Y. Coulibaly, K. Sacko, B. Berthé, Hibrahima Diallo, A. Traoré
Severe acute malnutrition still constitutes a worrying public health problem today. In its complicated form, it remains a significant cause of infant mortality in our countries. Objective: To study the epidemiological-clinical and therapeutic aspects of Severe Acute Malnutrition (SAM) complicated by anemia. Methodology: This is a retrospective descriptive study from 2019-2020 and prospective 2021 which took place at the Mali hospital. The study focused on all children aged 6 to 59 months hospitalized for severe acute malnutrition complicated by anemia. The Results: From January 1, 2019 to December 31, 2021, we screened 5,676 children among whom 200 children were diagnosed with SAM complicated by anemia with a hospital frequency of 3.52%. Children under 5 years old were the most represented with 85.5% of cases. There was no predominance of sex, the ratio =1. In our study, marasmus was the majority with a rate of 88.5% followed by kwashiorkor 7% and the mixed form 4.5%. The main complications observed were dehydration, fever, severe anemia and hypoglycemia with respective rates of 27%, 16%, 13.5% and 9.5%. The patient profile had hypochromic microcytic anemia with a number of 167 or 83.5% most often linked to iron deficiency. Gastroenteritis, pneumonia, malaria, and cerebral palsy were the most frequent associated pathologies during our study with respective rates of 48.5%, 34%, 26% and 12.5%. Conclusion: At the end of our study at the Mali hospital where the investigation took place, we managed to conclude that children aged 6 to 59 months who were screened for severe acute malnutrition had severe anemia with a rate of 13.5% microcytic type to 83.5% which explains that iron deficiency was the most plausible cause and 57% of these children screened had pallor.
{"title":"Epidemioclinical and Therapeutic Aspects of Malnutrition at Pediatrics Department of Mali Hospital","authors":"Aboubacar Sangaré, Mohamed Diabaté, Korotoum W. Diallo, Y. Coulibaly, K. Sacko, B. Berthé, Hibrahima Diallo, A. Traoré","doi":"10.36347/sasjm.2024.v10i06.001","DOIUrl":"https://doi.org/10.36347/sasjm.2024.v10i06.001","url":null,"abstract":"Severe acute malnutrition still constitutes a worrying public health problem today. In its complicated form, it remains a significant cause of infant mortality in our countries. Objective: To study the epidemiological-clinical and therapeutic aspects of Severe Acute Malnutrition (SAM) complicated by anemia. Methodology: This is a retrospective descriptive study from 2019-2020 and prospective 2021 which took place at the Mali hospital. The study focused on all children aged 6 to 59 months hospitalized for severe acute malnutrition complicated by anemia. The Results: From January 1, 2019 to December 31, 2021, we screened 5,676 children among whom 200 children were diagnosed with SAM complicated by anemia with a hospital frequency of 3.52%. Children under 5 years old were the most represented with 85.5% of cases. There was no predominance of sex, the ratio =1. In our study, marasmus was the majority with a rate of 88.5% followed by kwashiorkor 7% and the mixed form 4.5%. The main complications observed were dehydration, fever, severe anemia and hypoglycemia with respective rates of 27%, 16%, 13.5% and 9.5%. The patient profile had hypochromic microcytic anemia with a number of 167 or 83.5% most often linked to iron deficiency. Gastroenteritis, pneumonia, malaria, and cerebral palsy were the most frequent associated pathologies during our study with respective rates of 48.5%, 34%, 26% and 12.5%. Conclusion: At the end of our study at the Mali hospital where the investigation took place, we managed to conclude that children aged 6 to 59 months who were screened for severe acute malnutrition had severe anemia with a rate of 13.5% microcytic type to 83.5% which explains that iron deficiency was the most plausible cause and 57% of these children screened had pallor.","PeriodicalId":508512,"journal":{"name":"SAS Journal of Medicine","volume":"68 50","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141276641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-01DOI: 10.36347/sasjm.2024.v10i03.002
Yasir Altuwairqi
Background: Patients who suffer from psychiatric disorders have a higher likelihood of developing Type 2 Diabetes Mellitus (T2DM). Determining the prevalence of T2DM among individuals with psychiatric disorders is challenging due to the underdiagnosis of diabetes among this population. Objective: This study aimed to investigate the prevalence and risk factors of T2DM among adult psychiatric patients in Taif Mental Hospital, Saudi Arabia. Method: A cross-sectional study was conducted among adult psychiatric patients from June to November 2023 using a data collection sheet comprised of socio-demographic characteristics, the prevalence of T2DM, and the factors that may contribute to T2DM. Results: A study was conducted on 138 patients with psychiatric orders, most of whom (95.7%) were Saudi nationals, with 60.9% of them being female. Patients had a mean (Standard deviation [SD]) age of 42.7 (13.45) years old and a mean (SD) body mass index (BMI) of 29.3 (6.59) kg/m2. The patients had been suffering from psychiatric disorders for a mean (SD) of years of 10.3 (9.34) years. The prevalence of T2DM among patients with psychiatric disorders was 23.2%. The psychiatric patients aged more than 40 years (37.5%) had a significantly higher prevalence of T2DM compared to those aged less than or equal to 40 years (7.6%) (p<0.001). The patients with anxiety disorders (42.1%) had a significantly higher prevalence of T2DM compared to those who had other psychotic disorders (20.2%) (p=0.044). Psychiatric patients with complications (47.2%) had a significantly higher prevalence of T2DM compared to those who had not (7.3%) (p<0.001). Conclusion: Our study provides further evidence of the association between psychiatric disorders and an increased risk of T2DM. Implementing regular screening programs, managing anxiety disorders, promoting a healthy lifestyle, and providing comprehensive care are recommended for psychiatric patients with T2DM and comorbidities.
{"title":"Prevalence and Major Risk Factors of Type 2 Diabetes Mellitus Among Adult Psychiatric Patients in Taif Mental Hospital in Saudi Arabia","authors":"Yasir Altuwairqi","doi":"10.36347/sasjm.2024.v10i03.002","DOIUrl":"https://doi.org/10.36347/sasjm.2024.v10i03.002","url":null,"abstract":"Background: Patients who suffer from psychiatric disorders have a higher likelihood of developing Type 2 Diabetes Mellitus (T2DM). Determining the prevalence of T2DM among individuals with psychiatric disorders is challenging due to the underdiagnosis of diabetes among this population. Objective: This study aimed to investigate the prevalence and risk factors of T2DM among adult psychiatric patients in Taif Mental Hospital, Saudi Arabia. Method: A cross-sectional study was conducted among adult psychiatric patients from June to November 2023 using a data collection sheet comprised of socio-demographic characteristics, the prevalence of T2DM, and the factors that may contribute to T2DM. Results: A study was conducted on 138 patients with psychiatric orders, most of whom (95.7%) were Saudi nationals, with 60.9% of them being female. Patients had a mean (Standard deviation [SD]) age of 42.7 (13.45) years old and a mean (SD) body mass index (BMI) of 29.3 (6.59) kg/m2. The patients had been suffering from psychiatric disorders for a mean (SD) of years of 10.3 (9.34) years. The prevalence of T2DM among patients with psychiatric disorders was 23.2%. The psychiatric patients aged more than 40 years (37.5%) had a significantly higher prevalence of T2DM compared to those aged less than or equal to 40 years (7.6%) (p<0.001). The patients with anxiety disorders (42.1%) had a significantly higher prevalence of T2DM compared to those who had other psychotic disorders (20.2%) (p=0.044). Psychiatric patients with complications (47.2%) had a significantly higher prevalence of T2DM compared to those who had not (7.3%) (p<0.001). Conclusion: Our study provides further evidence of the association between psychiatric disorders and an increased risk of T2DM. Implementing regular screening programs, managing anxiety disorders, promoting a healthy lifestyle, and providing comprehensive care are recommended for psychiatric patients with T2DM and comorbidities.","PeriodicalId":508512,"journal":{"name":"SAS Journal of Medicine","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-02-14DOI: 10.36347/sasjm.2024.v10i02.009
I. Katir, F. E. Omari
The research described in this paper resulted from the study of the relatives of problem drug users called “affected family members” (AFM) involving two practitioners in our Psychiatric University Hospital Ar-Razi within the timeframe of January 2022 to April 2022. The objective of this research was simply to interview 64 close AFM, with the identification occurring through external consultations. Quantitative and qualitative results show that large numbers of these relatives reported many negative experiences, reporting both psychiatric and psychosomatic issues. Relatives reported many negative effects in terms of how they endure stigma and how the experiences had affected their health. They also described various coping mechanisms, and the extent of the support which they had received. The results are discussed in terms of coping, perceived stigma, health consequences, quality of life and it focuses on the difficulties, feelings, and interactions they face due to their loved one's substance use. The AFMs represent a vulnerable population susceptible to adverse health-related consequences. Therefore, they must be systematically included as pivotal targets for treatment protocols.
{"title":"Examining the Experiences of Affected Family Members in Morocco: A Descriptive Study of 64 Cases","authors":"I. Katir, F. E. Omari","doi":"10.36347/sasjm.2024.v10i02.009","DOIUrl":"https://doi.org/10.36347/sasjm.2024.v10i02.009","url":null,"abstract":"The research described in this paper resulted from the study of the relatives of problem drug users called “affected family members” (AFM) involving two practitioners in our Psychiatric University Hospital Ar-Razi within the timeframe of January 2022 to April 2022. The objective of this research was simply to interview 64 close AFM, with the identification occurring through external consultations. Quantitative and qualitative results show that large numbers of these relatives reported many negative experiences, reporting both psychiatric and psychosomatic issues. Relatives reported many negative effects in terms of how they endure stigma and how the experiences had affected their health. They also described various coping mechanisms, and the extent of the support which they had received. The results are discussed in terms of coping, perceived stigma, health consequences, quality of life and it focuses on the difficulties, feelings, and interactions they face due to their loved one's substance use. The AFMs represent a vulnerable population susceptible to adverse health-related consequences. Therefore, they must be systematically included as pivotal targets for treatment protocols.","PeriodicalId":508512,"journal":{"name":"SAS Journal of Medicine","volume":"62 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：